Summary
Elevance Health, Inc. (then operating as WellPoint, Inc.) filed an 8-K on March 15, 2007, to disclose its upcoming meetings with securities analysts and investors. The primary purpose of these meetings, scheduled between March 16 and March 31, 2007, was to reaffirm the company's confidence in meeting previously issued earnings expectations. These expectations were originally communicated on January 24, 2007, through a press release and conference call, with a copy of that release furnished as an exhibit to a prior 8-K filing. This disclosure signals management's intent to provide a consistent outlook to the investment community and manage expectations regarding the company's financial performance during that period.
Key Highlights
- 1Company confirmed upcoming meetings with securities analysts and investors from March 16 to March 31, 2007.
- 2Purpose of meetings was to confirm ability to meet previously stated earnings expectations.
- 3Earnings expectations were initially provided on January 24, 2007, via a press release and conference call.
- 4The press release from January 24, 2007, was attached as an exhibit to a prior 8-K filing.
- 5This filing is a Regulation FD disclosure, aiming to ensure broad dissemination of information.
- 6Information furnished in this 8-K is not considered 'filed' for Section 18 purposes and will not be incorporated into future filings under the Securities Act.
Frequently Asked Questions
The main purpose of this 8-K filing was to inform the public and the investment community about upcoming meetings between WellPoint's officers and securities analysts/investors. The company intended to use these meetings to reaffirm its confidence in meeting previously announced earnings expectations.
The original earnings expectations were communicated by WellPoint on January 24, 2007, through a press release and a conference call.
No, this 8-K filing does not contain new financial performance data. It serves as a Regulation FD disclosure to confirm the company's expectation to meet previously stated financial guidance and to inform about upcoming investor communications.
The filing explicitly states that the information furnished in this report shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 and will not be incorporated by reference into any future filings under the Securities Act of 1933. This is a standard disclaimer for Regulation FD disclosures.